Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.18p
   
  • Change Today:
    -0.21p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 759,115
  • Market Cap: £9.08m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £32,448
Lisa Baderoon 583,963 £12,730
Tim Franklin 525,000 £11,445

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 66,161,974 £1,442,331
Luca & Associates AG 22,000,000 £479,600
Invesco Ltd 17,872,341 £389,617
Aviva Investors Global 11,285,180 £246,017
Alora Pharmaceuticals LLC 10,909,091 £237,818
M&G Investments 7,600,000 £165,680
Prudential plc 7,600,000 £165,680
Capital Income Builder 4,870,367 £106,174
Dr R Zimmer 4,551,553 £99,224
Odey Asset Management 3,433,319 £74,846
Rhone Trustees (Switzerland) SA 3,386,000 £73,815
Pictet Overseas Trust Corporation Limited 3,287,500 £71,668

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.18p
Change Today -0.21p
% Change -8.60 %
52 Week High 3.42
52 Week Low 0.85
Volume 759,115
Shares Issued 416.44m
Market Cap £9.08m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.73% below the market average64.73% below the market average64.73% below the market average64.73% below the market average64.73% below the market average
13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average
Price Trend
22.82% below the market average22.82% below the market average22.82% below the market average22.82% below the market average22.82% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
16:28 200 @ 2.10p
16:00 26,328 @ 2.20p
15:45 29,836 @ 2.20p
15:23 1,962 @ 2.19p
14:45 90,413 @ 2.17p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page